These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25373797)

  • 1. Regional Radiation Pneumonitis After SIRT of a Subcapsular Liver Metastasis: What is the Effect of Direct Beta Irradiation?
    Dobrocky T; Fuerstner M; Klaeser B; Lopez-Benitez R; Wälti YB; Kara L
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):1025-30. PubMed ID: 25373797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings.
    Lin M
    AJR Am J Roentgenol; 1994 Jun; 162(6):1300-2. PubMed ID: 8191985
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review.
    Wright CL; Werner JD; Tran JM; Gates VL; Rikabi AA; Shah MH; Salem R
    J Vasc Interv Radiol; 2012 May; 23(5):669-74. PubMed ID: 22525023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
    Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS
    Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.
    Leung TW; Lau WY; Ho SK; Ward SC; Chow JH; Chan MS; Metreweli C; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):919-24. PubMed ID: 7591903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A surreptitious trip to the lungs.
    Courtright KR; Kotloff RM
    Ann Am Thorac Soc; 2014 Jan; 11(1):137-40. PubMed ID: 24460448
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report.
    Kesim S; Ones T; Eryuksel E; Baltacioglu F; Tureli D; Ozguven S; Erdil TY
    BMC Med Imaging; 2020 May; 20(1):52. PubMed ID: 32429910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
    Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
    Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.
    King J; Quinn R; Glenn DM; Janssen J; Tong D; Liaw W; Morris DL
    Cancer; 2008 Sep; 113(5):921-9. PubMed ID: 18618495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
    Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; Philips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA
    Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leiomyosarcoma of the inferior vena cava].
    Schultz JD; Ronellenfitsch U; Hohenberger P; Michaely H; Ströbel P; Post S; Schwarzbach M
    Zentralbl Chir; 2011 Aug; 136(4):391-3. PubMed ID: 20945289
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective internal radiation therapy (SIRT) in primary or secondary liver cancer.
    Prompers L; Bucerius J; Brans B; Temur Y; Berger L; Mottaghy FM
    Methods; 2011 Nov; 55(3):253-7. PubMed ID: 21964397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
    Pöpperl G; Helmberger T; Münzing W; Schmid R; Jacobs TF; Tatsch K
    Cancer Biother Radiopharm; 2005 Apr; 20(2):200-8. PubMed ID: 15869456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
    Konda A; Savin MA; Cappell MS; Duffy MC
    Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of arteriohepatovenous shunting by temporary balloon occlusion in patients undergoing radioembolization.
    Bester L; Salem R
    J Vasc Interv Radiol; 2007 Oct; 18(10):1310-4. PubMed ID: 17911524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
    Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
    J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective internal radiation therapy in patients with carcinoid liver metastases.
    Granberg D; Garske U; Welin S; Kindmark H; Oberg K; Eriksson B; Nyman R
    Acta Oncol; 2008; 47(6):1169-71. PubMed ID: 18607860
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease.
    Turkmen C; Ucar A; Poyanli A; Vatankulu B; Ozkan G; Basaran M; Serin K; Sanli Y; Adalet I
    Cancer Biother Radiopharm; 2013 Sep; 28(7):534-40. PubMed ID: 23647219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.